2-naphthol has been researched along with concanavalin a in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Chan, H; Chan-Yeung, M; Frew, AJ | 1 |
Jeong, MH; Jeong, SK; Jo, WS; Kang, YR; Kim, JS; Lee, CG; Oh, SJ | 1 |
2 other study(ies) available for 2-naphthol and concanavalin a
Article | Year |
---|---|
Lack of role for mononuclear cell-derived histamine releasing factors in occupational asthma due to western red cedar.
Topics: Adult; Allergens; Antibody Specificity; Asthma; Basophil Degranulation Test; Biological Factors; Bronchial Provocation Tests; Concanavalin A; Dust; Female; Histamine Release; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Leukocytes, Mononuclear; Lignans; Male; Middle Aged; Naphthols; Occupational Diseases; Plant Lectins; Poaceae; Pollen; Serum Albumin; Trees; Wood | 1993 |
The resveratrol analogue, HS‑1793, enhances the effects of radiation therapy through the induction of anti‑tumor immunity in mammary tumor growth.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoradiotherapy; Concanavalin A; Female; Interleukin-10; Mammary Neoplasms, Experimental; Mice; Naphthols; Radiation-Sensitizing Agents; Resorcinols; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |